Investing

Thursday's Top Analyst Upgrades and Downgrades: AMD, Clover Health, Peloton, Starbucks, Unilever and More

Alkermes PLC (NASDAQ: ALKS): BofA Securities downgraded the stock to Underperform from Neutral and has a $27 price target. The shares have a $25.00 consensus target, and Wednesday’s close was at $31.25.

Anheuser-Busch InBev S.A./N.V. (NYSE: BUD): JPMorgan lowered its Neutral rating to an Underweight with a $57 price target. That compares with a $78.22 consensus target and Wednesday’s close at $62.29.

Assembly Biosciences Inc. (NASDAQ: ASMB): William Blair downgraded it to a Market Perform from Outperform. Shares last closed at $3.90, and the consensus price target is $10.95.

Catabasis Pharmaceuticals Inc. (NASDAQ: CATB): Wedbush started coverage with an Outperform rating and a $16 price target. The $5.50 consensus target is way below Wednesday’s close at $9.41.

Clover Health Investments Corp. (NASDAQ: CLOV): Citigroup resumed coverage with a Neutral rating and a $10 price target. Shares most recently closed at $8.47 and have a consensus price target of $9.33.


Gaming and Leisure Properties Inc. (NASDAQ: GLPI): CapitalOne initiated coverage with an Overweight rating and a $54 price target. The shares last closed at $50.04, and the consensus price target is $53.11.

Materialise N.V. (NASDAQ: MTLS): Stifel initiated coverage with a Buy rating and a $30 price target. Shares last closed at $22.91, and the consensus target price is $26.55.

Okta Inc. (NASDAQ: OKTA): Needham upgraded the stock to Buy from Hold and has a $320 price target. Shares last closed at $264.76, but they have traded as high as $294.00 in the past year.

Peloton Interactive Inc. (NASDAQ: PTON): This is the Zacks Bear of the Day. The analyst points out that it is nothing more than an exercise equipment company, operating in a highly saturated space with low barriers to entry. Shares closed most recently at $100.04 apiece and have a consensus price target of $134.60.